Santa Barbara, CANCT06810219Now EnrollingIRB Ready

ALS (Amyotrophic Lateral Sclerosis) Clinical Trial in Santa Barbara, CA

Access cutting-edge als (amyotrophic lateral sclerosis) treatment through this clinical trial at a research site in Santa Barbara. Study-provided care at no cost to qualified participants.

Sponsored by Cognixion

Quick Self-Assessment

See if you qualify for this Santa Barbara location

Preparing your pre-screening questions…

Expert Care in Santa Barbara

Access als (amyotrophic lateral sclerosis) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related als (amyotrophic lateral sclerosis) treatment provided free

Apply for This Santa Barbara Location

Check if you qualify for this als (amyotrophic lateral sclerosis) clinical trial in Santa Barbara, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Santa Barbara

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Santa Barbara site if eligible
  4. 4Begin participation

About This ALS (Amyotrophic Lateral Sclerosis) Study in Santa Barbara

The goal of this study is refine the usability of a BCI based communication platform. The study will take place in the greater Los Angeles area and will enroll up to 10 participants with late stage ALS. Each subject will receive a Cognixion Axon-R augmented reality brain computer interface and associated communication software. The study duration is 3 months for each participant. The key questions that will be addressed in this study are: 1. How quickly can participants learn and gain confidence with a pure BCI interface. 2. How effective are alternate input modalities including eye tracking for this use case. 3. Identify the extent to which generative AI based personalization impacts the communication quality. Key measures include: ITR - information transfer rate SUS - system usability scale

Sponsor: Cognixion

Who Can Participate

Inclusion Criteria

Must have someone (LAR) who can consent to their participation and who will be present in the study alongside the participant
Must have a designated individual who can be trained on the Cognixion system
Fluent in understanding English
18 years or older
Must have ALS and need an assistive communication device
Must be able to engage in volitional eye opening and sustain eye opening independently for x duration
Must have a way to communicate apart from using the Cognixion device such as vocalizations, head nod, eye blinks, eyebrow raises, etc. At a minimum, reliable way of communicating "Yes" and "No"

Exclusion Criteria

Disruption in English comprehension, either due to lack of fluent proficiency or due to a developmental/acquired language disorder (e.g. aphasia)
Severely hearing impaired or deaf
Sensitivity to flashing lights
History of epilepsy and/or seizures
Vision disorders restricting the visual field such as glaucoma, diplopia (double vision), nystagmus (involuntary eye movements)
History of vertigo or other vestibular disorders
Scalp that is prone to irritation, inflammation, injury, or infectious process

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Santa Barbara?

Yes, this clinical trial (NCT06810219) has an active research site in Santa Barbara, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

ALS (Amyotrophic Lateral Sclerosis) Treatment Options in Santa Barbara, CA

If you're searching for als (amyotrophic lateral sclerosis) treatment options in Santa Barbara, CA, this clinical trial (NCT06810219) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Santa Barbara research site is actively enrolling participants for this clinical trial. You'll receive care from experienced als (amyotrophic lateral sclerosis) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all als (amyotrophic lateral sclerosis) clinical trials near you to find additional studies recruiting in your area.

More ALS Trials in Santa Barbara, CA

See all als clinical trials recruiting in Santa Barbara — not just this study.

Browse ALS Trials in Santa Barbara

Ready to Join in Santa Barbara?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Santa Barbara, CA